GILD
58
2
BK
65
2
PHM
50
2
AES
49
-2
EMN
42
2
SBUX
39
3
IVZ
50
2
EXR
33
2
GM
63
2
MET
60
2
FMC
20
-2
MNST
59
7
PG
46
3
UNM
70
2
CVS
32
3
ROST
66
4
HON
64
4
ICE
57
2
ZTS
43
3
BWA
45
3
GILD
58
2
BK
65
2
PHM
50
2
AES
49
-2
EMN
42
2
SBUX
39
3
IVZ
50
2
EXR
33
2
GM
63
2
MET
60
2
FMC
20
-2
MNST
59
7
PG
46
3
UNM
70
2
CVS
32
3
ROST
66
4
HON
64
4
ICE
57
2
ZTS
43
3
BWA
45
3
Financhill
Back

Poseida Therapeutics Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
48

PSTX
Poseida Therapeutics

Last Price:
$9.50
Seasonality Move:
-14.94%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Poseida Therapeutics Stock Forecast

  • Over the next 52 weeks, Poseida Therapeutics has on average historically risen by 25.6% based on the past 4 years of stock performance.
  • Poseida Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Poseida Therapeutics Stock Undervalued?
    The current Poseida Therapeutics [PSTX] share price is $9.51. The Score for PSTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PSTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Poseida Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Poseida Therapeutics has on average historically risen by 25.6% based on the past 4 years of stock performance.

Poseida Therapeutics Stock Rating

Sell
48
Poseida Therapeutics (PSTX) is a Sell

Is Poseida Therapeutics overpriced?

  • Poseida Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Poseida Therapeutics Stock Price History

Is PSTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
poseida.com

52-Week Data

52-Week High:
9.58
52-Week Low:
1.87

Prediction Charts

Market Cap:
926.9M
Price in USD:
9.51
Volume:
647.8K
Beta:
1.65

Technical Analysis

SMA50:
5.54
SMA100:
4.21
SMA200:
3.57
52-Wk Change:
183.04%

Stock Predictions

  • Is Poseida Therapeutics stock public?
    Yes, Poseida Therapeutics is a publicly traded company.
  • What is the Poseida Therapeutics stock quote today?
    The Poseida Therapeutics stock price is 9.51 USD today.
  • How to buy Poseida Therapeutics stock online?
    You can buy Poseida Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-6 9.37 9.36 9.40 9.36
Dec-9 9.40 9.44 9.48 9.35
Dec-10 9.42 9.45 9.50 9.40
Dec-11 9.45 9.51 9.53 9.40
Dec-12 9.45 9.50 9.58 9.45
Dec-13 9.50 9.51 9.55 9.48
Dec-16 9.50 9.51 9.53 9.48
Dec-17 9.49 9.50 9.56 9.49
Dec-18 9.52 9.44 9.55 9.40
Dec-19 9.46 9.41 9.49 9.40
Dec-20 9.38 9.47 9.49 9.36
Dec-23 9.41 9.48 9.49 9.41
Dec-24 9.47 9.49 9.50 9.45
Dec-26 9.47 9.51 9.52 9.43

Poseida Therapeutics Earnings

Poseida Therapeutics Earnings Report: Per Share Poseida Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Poseida Therapeutics Forecast Revenue Growth

Poseida Therapeutics Stock Analysis: Historical quarterly revenues per share for Poseida Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and a decrease next year of $1.08 per share.

* Poseida Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.